Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Abstract Neurodegenerative diseases, including Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system. The potential of numerous antidiabetic agents to m...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-11-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-024-01090-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|